This paper looks at the trends and topics that will shape the oncology market in 2024. In it, we address KRAS, CAR-T therapies, radiopharmaceuticals, and targeted protein degradation (TPD).
Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
